Combination of an implantable defibrillator multi-sensor heart failure index and an apnea index for the prediction of atrial high-rate events

• Published in: Europace (London, England) England), 2023-04, Vol.25 (4), p.1467-1474
• Main Authors: Bertini, Matteo, Vitali, Francesco, D’Onofrio, Antonio, Vitulano, Gennaro, Calò, Leonardo, Savarese, Gianluca, Santobuono, Vincenzo Ezio, Dello Russo, Antonio, Mattera, Agostino, Santoro, Amato, Calvanese, Raimondo, Arena, Giuseppe, Amellone, Claudia, Ziacchi, Matteo, Palmisano, Pietro, Santini, Luca, Mazza, Andrea, Campari, Monica, Valsecchi, Sergio, Boriani, Giuseppe
• Format: Article
• Language: English
• Subjects: Atrial Fibrillation - diagnosis; Atrial Fibrillation - epidemiology; Atrial Fibrillation - therapy; Clinical Research; Defibrillators, Implantable - adverse effects; Heart Failure - diagnosis; Heart Failure - epidemiology; Heart Failure - therapy; Humans; Risk Assessment; Sleep Apnea Syndromes
• ISSN: 1099-5129; 1532-2092; 1532-2092
• DOI: 10.1093/europace/euad052

Abstract Aims Patients with atrial fibrillation frequently experience sleep disorder breathing, and both conditions are highly prevalent in presence of heart failure (HF). We explored the association between the combination of an HF and a sleep apnoea (SA) index and the incidence of atrial high-rate events (AHRE) in patients with implantable defibrillators (ICDs). Methods and results Data were prospectively collected from 411 consecutive HF patients with ICD. The IN-alert HF state was measured by the multi-sensor HeartLogic Index (>16), and the ICD-measured Respiratory Disturbance Index (RDI) was computed to identify severe SA. The endpoints were as follows: daily AHRE burden of ≥5 min, ≥6 h, and ≥23 h. During a median follow-up of 26 months, the time IN-alert HF state was 13% of the total observation period. The RDI value was ≥30 episodes/h (severe SA) during 58% of the observation period. An AHRE burden of ≥5 min/day was documented in 139 (34%) patients, ≥6 h/day in 89 (22%) patients, and ≥23 h/day in 68 (17%) patients. The IN-alert HF state was independently associated with AHRE regardless of the daily burden threshold: hazard ratios from 2.17 for ≥5 min/day to 3.43 for ≥23 h/day (P < 0.01). An RDI ≥ 30 episodes/h was associated only with AHRE burden ≥5 min/day [hazard ratio 1.55 (95% confidence interval: 1.11–2.16), P = 0.001]. The combination of IN-alert HF state and RDI ≥ 30 episodes/h accounted for only 6% of the follow-up period and was associated with high rates of AHRE occurrence (from 28 events/100 patient-years for AHRE burden ≥5 min/day to 22 events/100 patient-years for AHRE burden ≥23 h/day). Conclusions In HF patients, the occurrence of AHRE is independently associated with the ICD-measured IN-alert HF state and RDI ≥ 30 episodes/h. The coexistence of these two conditions occurs rarely but is associated with a very high rate of AHRE occurrence. Clinical trial registration URL: http://clinicaltrials.gov/Identifier: NCT02275637. Graphical Abstract Graphical Abstract